308 related articles for article (PubMed ID: 19286850)
1. The gap between practice and guidelines in the choice of first-line disease modifying antirheumatic drug in early rheumatoid arthritis: results from the ESPOIR cohort.
Benhamou M; Rincheval N; Roy C; Foltz V; Rozenberg S; Sibilia J; Schaeverbeke T; Bourgeois P; Ravaud P; Fautrel B
J Rheumatol; 2009 May; 36(5):934-42. PubMed ID: 19286850
[TBL] [Abstract][Full Text] [Related]
2. Update of French society for rheumatology recommendations for managing rheumatoid arthritis.
Daien C; Hua C; Gaujoux-Viala C; Cantagrel A; Dubremetz M; Dougados M; Fautrel B; Mariette X; Nayral N; Richez C; Saraux A; Thibaud G; Wendling D; Gossec L; Combe B
Joint Bone Spine; 2019 Mar; 86(2):135-150. PubMed ID: 30315988
[TBL] [Abstract][Full Text] [Related]
3. Identifying factors associated with concordance with the American College of Rheumatology rheumatoid arthritis treatment recommendations.
Harrold LR; Reed GW; Kremer JM; Curtis JR; Solomon DH; Hochberg MC; Kavanaugh A; Saunders KC; Shan Y; Spruill TM; Pappas DA; Greenberg JD
Arthritis Res Ther; 2016 Apr; 18():94. PubMed ID: 27118040
[TBL] [Abstract][Full Text] [Related]
4. A Population-Based Approach to Reporting System-Level Performance Measures for Rheumatoid Arthritis Care.
Barber CEH; Marshall DA; Szefer E; Barnabe C; Shiff NJ; Bykerk V; Homik J; Thorne JC; Ahluwalia V; Benseler S; Mosher D; Twilt M; Lacaille D
Arthritis Care Res (Hoboken); 2021 May; 73(5):640-648. PubMed ID: 32144843
[TBL] [Abstract][Full Text] [Related]
5. Association of Patient, Prescriber, and Region With the Initiation of First Prescription of Biologic Disease-Modifying Antirheumatic Drug Among Older Patients With Rheumatoid Arthritis and Identical Health Insurance Coverage.
Tatangelo M; Tomlinson G; Paterson JM; Ahluwalia V; Kopp A; Gomes T; Bansback N; Bombardier C
JAMA Netw Open; 2019 Dec; 2(12):e1917053. PubMed ID: 31808927
[TBL] [Abstract][Full Text] [Related]
6. Treatment Patterns with Disease-Modifying Antirheumatic Drugs in U.S. Veterans with Newly Diagnosed Rheumatoid Arthritis, Psoriatic Arthritis, or Ankylosing Spondylitis.
Walsh JA; Pei S; Penmetsa GK; Sauer BC; Patil V; Walker JH; Clewell J; Douglas KM; Clegg DO; Cannon GW; Halwani A
J Manag Care Spec Pharm; 2019 Nov; 25(11):1218-1228. PubMed ID: 31663467
[TBL] [Abstract][Full Text] [Related]
7. Practical progress in realisation of early diagnosis and treatment of patients with suspected rheumatoid arthritis: results from two matched questionnaires within three years.
Aletaha D; Eberl G; Nell VP; Machold KP; Smolen JS
Ann Rheum Dis; 2002 Jul; 61(7):630-4. PubMed ID: 12079906
[TBL] [Abstract][Full Text] [Related]
8. Trends in the use of disease modifying antirheumatic medications in rheumatoid arthritis, 1980-1995: results from the National Ambulatory Medical Care Surveys.
Ward MM
J Rheumatol; 1999 Mar; 26(3):546-50. PubMed ID: 10090160
[TBL] [Abstract][Full Text] [Related]
9. Prescribing practices in a US cohort of rheumatoid arthritis patients before and after publication of the American College of Rheumatology treatment recommendations.
Harrold LR; Harrington JT; Curtis JR; Furst DE; Bentley MJ; Shan Y; Reed G; Kremer J; Greenberg JD
Arthritis Rheum; 2012 Mar; 64(3):630-8. PubMed ID: 21953645
[TBL] [Abstract][Full Text] [Related]
10. Rheumatoid arthritis patients and rheumatologists approach the decision to escalate care differently: results of a maximum difference scaling experiment.
van Hulst LT; Kievit W; van Bommel R; van Riel PL; Fraenkel L
Arthritis Care Res (Hoboken); 2011 Oct; 63(10):1407-14. PubMed ID: 21748861
[TBL] [Abstract][Full Text] [Related]
11. Care quality for rheumatoid arthritis patients in Quebec.
Slim Z; Moura CS; Bernatsky S; Rahme E
Int J Rheum Dis; 2019 Jul; 22(7):1233-1238. PubMed ID: 30993889
[TBL] [Abstract][Full Text] [Related]
12. Patterns of the initiation of disease-modifying antirheumatic drugs in incident rheumatoid arthritis: a German perspective based on nationwide ambulatory drug prescription data.
Steffen A; Holstiege J; Klimke K; Akmatov MK; Bätzing J
Rheumatol Int; 2018 Nov; 38(11):2111-2120. PubMed ID: 30306254
[TBL] [Abstract][Full Text] [Related]
13. Belgian rheumatologists' perception on eligibility of RA patients for anti-TNF treatment matches more closely Dutch rather than Belgian reimbursement criteria.
Geens E; Geusens P; Vanhoof J; Berghs H; Praet J; Esselens G; Lens S; Dufour JP; Vandenberghe M; Van Mullem X; Westhovens R; Verschueren P
Rheumatology (Oxford); 2009 May; 48(5):546-50. PubMed ID: 19254920
[TBL] [Abstract][Full Text] [Related]
14. Treatment Strategies in Early Rheumatoid Arthritis Methotrexate Management: Results From a Prospective Cohort.
Moura CS; Schieir O; Valois MF; Thorne C; Bartlett SJ; Pope JE; Hitchon CA; Boire G; Haraoui B; Hazlewood GS; Keystone EC; Tin D; Bykerk VP; Bernatsky S;
Arthritis Care Res (Hoboken); 2020 Aug; 72(8):1104-1111. PubMed ID: 31112011
[TBL] [Abstract][Full Text] [Related]
15. Disease activity-based management of rheumatoid arthritis in Dutch daily clinical practice has improved over the past decade.
Spijk-de Jonge MJ; Weijers JM; Boerboom LWM; Huis AMP; Atsma F; Van Hulst LTC; van de Laar MAFJ; Hulscher MEJL; van Riel PLCM
Clin Rheumatol; 2020 Apr; 39(4):1131-1139. PubMed ID: 31997083
[TBL] [Abstract][Full Text] [Related]
16. Combination of disease-modifying antirheumatic drugs in the treatment of rheumatoid arthritis. A survey of Alabama rheumatologists.
Baum SK; Tracy IC; Henderson EH; Alarcón GS
Arthritis Care Res; 1991 Mar; 4(1):48-51. PubMed ID: 11188587
[TBL] [Abstract][Full Text] [Related]
17. Laboratory screening for side effects of disease modifying antirheumatic drugs in daily rheumatological practice.
Simon CH; Vliet Vlieland TP; Dijkmans BA; Bernelot Moens HJ; Janssen M; Hazes JM; Franken HC; Vandenbroucke JP; Breedveld FC
Scand J Rheumatol; 1998; 27(3):170-9. PubMed ID: 9645411
[TBL] [Abstract][Full Text] [Related]
18. Treating rheumatoid arthritis to target: an Italian rheumatologists' survey on the acceptance of the treat-to-target recommendations.
Caporali R; Conti F; Covelli M; Govoni M; Salaffi F; Ventriglia G; Montecucco C
Clin Exp Rheumatol; 2014; 32(4):471-6. PubMed ID: 24960620
[TBL] [Abstract][Full Text] [Related]
19. First-line DMARD choice in early rheumatoid arthritis--do prognostic factors play a role?
Rachapalli SM; Williams R; Walsh DA; Young A; Kiely PD; Choy EH;
Rheumatology (Oxford); 2010 Jul; 49(7):1267-71. PubMed ID: 20008093
[TBL] [Abstract][Full Text] [Related]
20. Eligibility of rheumatoid arthritis patients for anti-TNF-alpha therapy according to the 2005 recommendations of the French and British Societies for Rheumatology.
Fautrel B; Flipo RM; Saraux A
Rheumatology (Oxford); 2008 Nov; 47(11):1698-703. PubMed ID: 18794185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
